EPO Patents = 2

Forward Citations = 2

Loading Chart...

9 inventors (with patents filed for the assignee):

Titus Kretzschmar (4 out of 9 patents)

Abdijapar Shamshiev (4 out of 9 patents)

Simone Schmitt (3 out of 6 patents)

4. Stefanie Grabulovski (3 out of 6 patents)

5. Thorsten Alexander Schafer (2 out of 3 patents)

6. Annemarie Honegger (1 out of 7 patents)

7. Alcide Barberis (1 out of 22 patents)

8. Adrian Auf Der Maur (1 out of 17 patents)

9. Peter Lichtlen (1 out of 9 patents)

10. Miriam Droste (1 patent)

11. Douglas Phillips (1 patent)

12. Titus Kretzschmar (0 patent)

5 patents: Sort by Forward Citations

1. 10626171 - Nucleic acid encoding antibody to human IL-1 beta (2020-04-21),

2. 10233238 - TNF alpha antibody or fragment thereof and methods of use (2019-03-19),

3. 10077302 - Method of inhibiting human IL-1 beta by administering an antibody to human IL-1 beta (2018-09-18),

4. 9914772 - Antibodies against IL-1 beta (2018-03-13),

5. 9512411 - Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK (2016-12-06),

Cell Medica Switzerland Ag is a clinical-stage biopharmaceutical company that is focused on developing cellular immunotherapies for the treatment of cancer and viral infections. Their proprietary T cell therapy platform aims to harness the power of the immune system to target and attack diseased cells. With a strong pipeline of innovative therapies, Cell Medica is dedicated to improving patient outcomes and advancing the field of cellular therapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#15 in Schlieren

#1,652 in Switzerland

Schlieren, Switzerland

Cell Medica Switzerland Ag